Sleemon Healthy Sleep Technology Co., Ltd. (SHA:603008)
China · Delayed Price · Currency is CNY 10.18
+0.07 (0.69%)
Sep 22, 2026, 2:39 PM CST
SHA:603008 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,723 | 7,543 | 6,352 | 6,590 | 11,061 | 14,887 | |
Market Cap Growth | -45.84% | 18.75% | -3.61% | -40.42% | -25.70% | 98.89% |
Enterprise Value | 4,781 | 7,884 | 6,950 | 7,397 | 11,962 | 15,497 |
Last Close Price | 10.11 | 20.48 | 16.01 | 15.84 | 26.50 | 35.94 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 31.24 | 19.70 | 15.37 | 46.56 | 26.64 |
Forward PE | 7.02 | 15.34 | 11.90 | 10.90 | 15.09 | 22.77 |
PS Ratio | 0.43 | 0.86 | 0.73 | 0.76 | 1.41 | 1.92 |
PB Ratio | 1.04 | 2.09 | 1.62 | 1.67 | 2.98 | 4.40 |
P/TBV Ratio | 1.24 | 2.47 | 1.96 | 2.07 | 3.72 | 5.48 |
P/FCF Ratio | 14.77 | 30.18 | 14.94 | 9.69 | - | 70.37 |
P/OCF Ratio | 4.70 | 8.97 | 8.07 | 5.26 | 13.15 | 21.16 |
PEG Ratio | - | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.56 | 0.89 | 0.80 | 0.85 | 1.53 | 1.99 |
EV/EBITDA Ratio | 12.81 | 13.54 | 11.02 | 9.70 | 24.69 | 18.79 |
EV/EBIT Ratio | 36.38 | 19.09 | 18.69 | 14.46 | 35.77 | 22.48 |
EV/FCF Ratio | 18.97 | 31.55 | 16.35 | 10.87 | - | 73.26 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.75 | 0.67 | 0.56 | 0.46 | 0.66 | 0.56 |
Debt / EBITDA Ratio | 7.21 | 3.67 | 3.51 | 2.40 | 4.22 | 2.16 |
Debt / FCF Ratio | 10.67 | 9.64 | 5.21 | 2.69 | - | 8.88 |
Net Debt / Equity Ratio | 0.28 | 0.04 | -0.05 | -0.07 | 0.07 | 0.04 |
Net Debt / EBITDA Ratio | 3.35 | 0.24 | -0.32 | -0.36 | 0.50 | 0.18 |
Net Debt / FCF Ratio | 3.97 | 0.57 | -0.47 | -0.40 | -18.10 | 0.69 |
Asset Turnover | 1.01 | 1.00 | 0.98 | 0.97 | 0.90 | 0.98 |
Inventory Turnover | 6.99 | 6.40 | 6.01 | 5.11 | 4.62 | 5.57 |
Quick Ratio | 0.77 | 0.81 | 0.82 | 0.78 | 0.79 | 0.78 |
Current Ratio | 1.03 | 1.12 | 1.09 | 1.08 | 1.10 | 1.10 |
Return on Equity (ROE) | -1.59% | 6.31% | 8.31% | 11.70% | 7.66% | 18.46% |
Return on Assets (ROA) | 0.96% | 2.94% | 2.61% | 3.56% | 2.41% | 5.43% |
Return on Invested Capital (ROIC) | 2.91% | 8.24% | 9.28% | 10.82% | 7.54% | 17.62% |
Return on Capital Employed (ROCE) | 3.20% | 9.20% | 8.40% | 11.30% | 7.60% | 17.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.65% | 3.20% | 5.08% | 6.51% | 2.15% | 3.75% |
FCF Yield | 6.77% | 3.31% | 6.69% | 10.32% | -0.12% | 1.42% |
Dividend Yield | 5.50% | 2.73% | 3.25% | 3.16% | 0.30% | 0.78% |
Payout Ratio | - | 150.61% | 80.09% | 21.41% | 79.50% | 29.42% |
Buyback Yield / Dilution | 3.04% | 2.07% | 1.84% | -0.84% | 0.57% | 1.64% |
Total Shareholder Return | 8.58% | 4.80% | 5.09% | 2.31% | 0.88% | 2.42% |